Mark Jeffrey DeLong - 29 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Issuer symbol
APLS
Transactions as of
29 Jan 2025
Net transactions value
-$10,776
Form type
4
Filing time
30 Jan 2025, 12:01:02 UTC
Previous filing
23 Jan 2025
Next filing
12 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $10,776 -365 -0.43% $29.52 84,308 29 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 28, 2025.